Cargando…

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies

Late gadolinium enhancement (LGE) is the most relevant tool of cardiac magnetic resonance for tissue characterization, and it plays a pivotal role for diagnostic and prognostic assessment of cardiomyopathies. The pattern of presentation of LGE allows differential diagnosis between ischaemic and non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Aquaro, Giovanni Donato, De Gori, Carmelo, Faggioni, Lorenzo, Parisella, Maria Luisa, Cioni, Dania, Lencioni, Riccardo, Neri, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132607/
https://www.ncbi.nlm.nih.gov/pubmed/37125322
http://dx.doi.org/10.1093/eurheartjsupp/suad015
_version_ 1785031419252178944
author Aquaro, Giovanni Donato
De Gori, Carmelo
Faggioni, Lorenzo
Parisella, Maria Luisa
Cioni, Dania
Lencioni, Riccardo
Neri, Emanuele
author_facet Aquaro, Giovanni Donato
De Gori, Carmelo
Faggioni, Lorenzo
Parisella, Maria Luisa
Cioni, Dania
Lencioni, Riccardo
Neri, Emanuele
author_sort Aquaro, Giovanni Donato
collection PubMed
description Late gadolinium enhancement (LGE) is the most relevant tool of cardiac magnetic resonance for tissue characterization, and it plays a pivotal role for diagnostic and prognostic assessment of cardiomyopathies. The pattern of presentation of LGE allows differential diagnosis between ischaemic and non-ischaemic heart disease with high diagnostic accuracy, and among different cardiomyopathies, specific presentation of LGE may help to make a diagnosis. Late gadolinium enhancement may be caused by conditions that significantly increase the interstitial space or, less frequently, that slow down Gd exit, like myocardial fibrosis. In chronic myocardial infarction, hypertrophic cardiomyopathies (HCM), dilated cardiomyopathy, Fabry disease, and other conditions, LGE is a marker of myocardial fibrosis, but also in patients with acute myocarditis where LGE may be also explained by the increase of interstitial space caused by interstitial oedema or by tissue infiltration of inflammatory cells. In cardiac amyloidosis, LGE represents myocardial fibrosis but the interstitial overload of amyloid proteins should also be considered as a potential cause of LGE. The identification of the pattern of presentation of LGE is also very important. In the ischaemic pattern, LGE always involves the subendocardial layer with more or less transmural extent, it is confluent, and every single scar should be located in the territory of one coronary artery. In the non-ischaemic pattern, LGE does not fulfil the previous criteria, being midwall, subepicardial, or mixed, not necessarily confluent or confined to a territory of one coronary artery. For cardiomyopathies, the exact pattern of non-ischaemic LGE is important. Quantitative analysis of LGE is required in some specific conditions as in HCM. Magnetic resonance imaging with LGE technique should be performed in every patient with suspect of cardiomyopathy. The lack of standardization of pulse sequence and mostly of quantification methods is the main limitation of LGE technique.
format Online
Article
Text
id pubmed-10132607
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101326072023-04-27 Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies Aquaro, Giovanni Donato De Gori, Carmelo Faggioni, Lorenzo Parisella, Maria Luisa Cioni, Dania Lencioni, Riccardo Neri, Emanuele Eur Heart J Suppl PLACE 2022 Supplement Paper Late gadolinium enhancement (LGE) is the most relevant tool of cardiac magnetic resonance for tissue characterization, and it plays a pivotal role for diagnostic and prognostic assessment of cardiomyopathies. The pattern of presentation of LGE allows differential diagnosis between ischaemic and non-ischaemic heart disease with high diagnostic accuracy, and among different cardiomyopathies, specific presentation of LGE may help to make a diagnosis. Late gadolinium enhancement may be caused by conditions that significantly increase the interstitial space or, less frequently, that slow down Gd exit, like myocardial fibrosis. In chronic myocardial infarction, hypertrophic cardiomyopathies (HCM), dilated cardiomyopathy, Fabry disease, and other conditions, LGE is a marker of myocardial fibrosis, but also in patients with acute myocarditis where LGE may be also explained by the increase of interstitial space caused by interstitial oedema or by tissue infiltration of inflammatory cells. In cardiac amyloidosis, LGE represents myocardial fibrosis but the interstitial overload of amyloid proteins should also be considered as a potential cause of LGE. The identification of the pattern of presentation of LGE is also very important. In the ischaemic pattern, LGE always involves the subendocardial layer with more or less transmural extent, it is confluent, and every single scar should be located in the territory of one coronary artery. In the non-ischaemic pattern, LGE does not fulfil the previous criteria, being midwall, subepicardial, or mixed, not necessarily confluent or confined to a territory of one coronary artery. For cardiomyopathies, the exact pattern of non-ischaemic LGE is important. Quantitative analysis of LGE is required in some specific conditions as in HCM. Magnetic resonance imaging with LGE technique should be performed in every patient with suspect of cardiomyopathy. The lack of standardization of pulse sequence and mostly of quantification methods is the main limitation of LGE technique. Oxford University Press 2023-04-26 /pmc/articles/PMC10132607/ /pubmed/37125322 http://dx.doi.org/10.1093/eurheartjsupp/suad015 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle PLACE 2022 Supplement Paper
Aquaro, Giovanni Donato
De Gori, Carmelo
Faggioni, Lorenzo
Parisella, Maria Luisa
Cioni, Dania
Lencioni, Riccardo
Neri, Emanuele
Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
title Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
title_full Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
title_fullStr Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
title_full_unstemmed Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
title_short Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
title_sort diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
topic PLACE 2022 Supplement Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132607/
https://www.ncbi.nlm.nih.gov/pubmed/37125322
http://dx.doi.org/10.1093/eurheartjsupp/suad015
work_keys_str_mv AT aquarogiovannidonato diagnosticandprognosticroleoflategadoliniumenhancementincardiomyopathies
AT degoricarmelo diagnosticandprognosticroleoflategadoliniumenhancementincardiomyopathies
AT faggionilorenzo diagnosticandprognosticroleoflategadoliniumenhancementincardiomyopathies
AT parisellamarialuisa diagnosticandprognosticroleoflategadoliniumenhancementincardiomyopathies
AT cionidania diagnosticandprognosticroleoflategadoliniumenhancementincardiomyopathies
AT lencioniriccardo diagnosticandprognosticroleoflategadoliniumenhancementincardiomyopathies
AT neriemanuele diagnosticandprognosticroleoflategadoliniumenhancementincardiomyopathies